LMARX
Price
$71.04
Change
-$0.26 (-0.36%)
Updated
Jul 31 closing price
Net Assets
705.48M
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

LMARX vs VSMAX

LMARX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
LMARX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMARX is a Buy and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. LMARX (705M). VSMAX pays higher dividends than LMARX: VSMAX (1.21) vs LMARX (0.00). LMARX was incepted earlier than VSMAX: LMARX (20 years) vs VSMAX (26 years). LMARX (1.48) is less costly to investors than VSMAX (0.05). LMARX is a more actively managed with annual turnover of: 33.00 vs. VSMAX (17.00). LMARX has a lower initial minimum investment than VSMAX: LMARX (0) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. LMARX (17.23). VSMAX return over 5 years is better than : 35.11 vs. LMARX (-0.10).
LMARXVSMAXLMARX / VSMAX
Total Expense Ratio1.450.052,900%
Annual Report Gross Expense Ratio1.480.052,960%
Fund Existence20 years26 years-
Gain YTD15.19414.588104%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets705M189B0%
Annual Yield % from dividends0.001.21-
Returns for 1 year17.2322.5876%
Returns for 3 years17.4743.4240%
Returns for 5 years-0.1035.11-0%
Returns for 10 years48.68155.9631%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H